On July 20, the medical network gave the doctor the commission report, the city health and family planning commission "wanted" two medicines!
▍ drug firms with gold sales were reported
In recent days, the industry has circulated a notice from taizhou health and family planning commission (hereinafter referred to as "notice") to conduct investigation on the sale of hexam-hexaminin tablets and the sales of allocillin sodium belt.
The notice said:
"By commission recently received a report, reflecting the XXX group production of sinomenium acutum had a pill and azlocillin sodium in taizhou hospitals with gold sales, factory representative for clinical drug use of hospitals and doctors to kickbacks, please the relevant medical units to report content checking, use of the above drug usage and departments do key research, found the problem in a timely manner is investigated, and the investigation and handling results reported by commission before July 24 (straight hospital report directly, other hospitals by various counties (city, area) the summary report after finishing) health and family planning."
"Manufacturers represent doctors and hospital rebates for clinical use." Such information is included in the report received. Can we stand idly by when such a report is received?
▍ town "wanted" two drugs, doctors, department
In "notice", the taizhou health and family planning commission asked all medical units in the city to conduct self-examination of the report, focusing on the use of the two drugs and the use of the department. The investigation shall be investigated and reported before July 24.
According to the public information, the two medicines sold by the tip-off, allocillin sodium, are the third-generation broad-spectrum semi-synthetic penicillin, and the general administration database shows that there are 84 approval Numbers in the country.
Among the top 50 pharmaceutical products of January ~ October released by the shandong health and family planning commission in 2016, aloucillin sodium was only 46th. There are many competing products and limited sales potential, which may be the real market situation of this product.
Another product, hexaminol tablets, is mainly used for anti-rheumatism and pain relief, as well as pharmacies to promote it on the Internet as a cancer drug.
▍ belt gold sales, the front-runner, everyone is "chaoyang Boyle"
Taizhou "notice" although say is very concise, but logically speaking, since this report can be processed concurrently notification is investigated, a person must be the kickbacks from the plot of the two drugs, the outcomes are presented to the dealing with development planning commission.
If you think about it, you can get the kickbacks, except that your peers are your own people.
Policy is suppressed, public security is arresting people, drug generation doctors jittery, people deeply hate.
Don't let medicine generation bear the sales task, drug companies to sign the guarantee of probity, medical institutions "nine" is not allowed, medicine generation record facial recognition - from the policy level to specific details, networks, all will be on killing drug kickbacks, thorough cleaning.
Add in the anti-water of our own people, say embattled, appropriately.
The drug companies are wrong-headed and still take the gold model. Even if we get it, we get it. In the opposite direction of policy, there are countless pairs of eyes staring at the target, and everyone could become a "morning aunt". It's a terrible power.
After the blue parker once wrote an analysis, more detailed task of health reform this year than last year, although on the surface not let everybody feel obvious "challenge" policy, but for drug firms, it is not easy last year, because of the impact is likely to be more thorough, more comprehensive.
There will be 14 reform supporting files need to be before the end of the year, 56 items need to gradually implement the reform big task, a medical representative for the record, have implemented two votes and even some enterprises will be killed, affect drug firms are revolutionary...
It seems that the drug companies are not going to be able to make the transition, wait and see, be prepared early, and start to act! |
